NASDAQ:MBX

Mbx Biosciences . Common Stock Stock News

Buy MBX

*Your capital is at risk

$48.40

+2.01 (+4.33%)

At Close: Jun 24, 2026

How Much Upside is Left in MBX Biosciences, Inc. (MBX)? Wall Street Analysts Think 80.6%

10:56am, Monday, 01'st Dec 2025

The mean of analysts' price targets for MBX Biosciences, Inc. (MBX) points to an 80.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement

Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus

10:22am, Monday, 01'st Dec 2025

MBX Biosciences' sharp rally highlights how Zacks' stock recommendations outpaced broader market gains across multiple portfolios.

This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones

03:38pm, Thursday, 27'th Nov 2025

Boston-based MPM BioImpact sold 1.3 million shares of MBX Biosciences worth an estimated $14.8 million in the third quarter. The move marked a full exit for MPM BioImpact, which reported holding no sh

MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference

08:00am, Tuesday, 18'th Nov 2025

CARMEL, Ind., Nov. 18, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide ther

Wall Street Analysts See a 142% Upside in MBX Biosciences, Inc. (MBX): Can the Stock Really Move This High?

10:56am, Friday, 14'th Nov 2025

The average of price targets set by Wall Street analysts indicates a potential upside of 142% in MBX Biosciences, Inc. (MBX). While the effectiveness of this highly sought-after metric is questionable

MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

08:00am, Thursday, 06'th Nov 2025

Reported positive topline results from the Phase 2 Avail™ trial of once-weekly canvuparatide in hypoparathyroidism (HP) Completed upsized public offering, raising approximately $200 million in gross

Wall Street Analysts Think MBX Biosciences, Inc. (MBX) Could Surge 228.51%: Read This Before Placing a Bet

10:55am, Wednesday, 29'th Oct 2025

The mean of analysts' price targets for MBX Biosciences, Inc. (MBX) points to a 228.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement

MBX Biosciences to Participate in November Investor Conferences

08:00am, Monday, 20'th Oct 2025

CARMEL, Ind., Oct. 20, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide ther

Wall Street Analysts See a 280.14% Upside in MBX Biosciences, Inc. (MBX): Can the Stock Really Move This High?

10:56am, Thursday, 09'th Oct 2025

The average of price targets set by Wall Street analysts indicates a potential upside of 280.1% in MBX Biosciences, Inc. (MBX). While the effectiveness of this highly sought-after metric is questionab

Insiders Snap Up $54M in Biotech and Offshore Driller Stocks

08:45am, Tuesday, 07'th Oct 2025

In the past week or so, some public offerings of stock prompted big insider buying.

MBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic Forum

08:00am, Monday, 29'th Sep 2025

CARMEL, Ind., Sept. 29, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide the

Stitch Fix Posts Q4 Results, Joins Transocean, MBX Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

08:24am, Thursday, 25'th Sep 2025

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Thursday.

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by